Delivery Order SPE2DB25D3202-SPE2DB25FTAEP

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,064.98 firm-fixed-price delivery order contract is for the supply of the medication Lo Loestrin Fe 1-10 Tablet 28s. The contract has an ultimate completion date of January 31, 2023 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order, valued at $1,124.52, is for the supply of the medication LO LOESTRIN FE 1-10 TABLET 28S. The contract has a period of performance through June 11, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,415.42, is a delivery order for the medical product "LO LOESTRIN FE 1-10 TABLET 28S". The contract has an ultimate completion date of April 9, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,126.11, is a firm fixed-price delivery order for the supply of Lo Loestrin Fe 1-10 tablets. The contract has an ultimate completion date of March 6, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,852.50 firm-fixed-price delivery order is for the supply of the prescription medication LO LOESTRIN FE 1-10 TABLET 28S, with a period of performance through May 7, 2025. The contract is not set aside for any particular business size or socioeconomic category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,553.96 firm fixed-price delivery order is for the medical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,756.95, is a delivery order for the supply of Lo Loestrin Fe 1-10 Tablet 28s. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,352.35 delivery order contract is for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a birth control medication. The contract has an ultimate completion date of August 9, 2022 and is a firm fixed-price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,452.13 firm fixed price delivery order is for the supply of Lo Loestrin FE 1-10 Tablet 28s, a medication. The award was made on September 26, 2024, with a completion date of September 27, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $13,069.60, is for the delivery of the medication LO LOESTRIN FE 140S. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB25D3202
    Indefinite Delivery Contract
  • SPE2DB25D3202-SPE2DB25FTAEP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,479.21 firm fixed-price delivery order is for the medication Lo Loestrin Fe 1-10 Tablet 28S, with an ultimate completion date of April 24, 2025.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award does not mention any set-aside designation, indicating open competition.

Generated 7/23/25, 10:02 AM